Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings save search
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: 58.58%
H: 67.22%
C: 42.09%
financial results results
Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update
Published: 2022-12-20 (Crawled : 23:00) - biospace.com/
VVOS | $2.72 2.26% 2.21% 34K
|
Health Technology
|
| O: 1.21%
H: 59.57%
C: 12.77%
therapeutics financial update results
Addex Provides Corporate Update and Financial Guidance
Published: 2022-07-21 (Crawled : 11:00) - biospace.com/
ADXN | News | $19.0 -9.35% -10.32% 20K
|
Health Technology
|
| O: 72.24%
H: 57.59%
C: 22.15%
update
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 18:00) - biospace.com/
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 12.98%
H: 51.63%
C: 44.6%
therapeutics financial update results
AquaBounty Technologies Announces Results for the Quarter and Year Ended December 31, 2021
Published: 2022-03-10 (Crawled : 18:00) - biospace.com/
AQB | $1.72 -1.71% -1.74% 16K
|
Health Technology
|
| O: -2.86%
H: 50.74%
C: 41.91%
ces results
InfuSystem Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
STMH | $0.1 -88.3% 2.2K
|
Manufacturing
|
| O: 0.0%
H: 49.0%
C: 39.5%
results
Nuo Therapeutics Provides Corporate and Business Update
Published: 2022-08-30 (Crawled : 13:00) - biospace.com/
AURX 4 | $0.95 116.67% 1K
|
|
| O: 7.41%
H: 48.28%
C: 48.28%
therapeutics update
Q BioMed Shows Significant Uptrend in Revenues in Year-End Update
Published: 2021-12-16 (Crawled : 14:30) - biospace.com/
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 47.83%
C: 44.93%
Athersys to Announce First Quarter Financial Results on May 6
Published: 2022-04-29 (Crawled : 14:00) - biospace.com/
ATHX | $0.1018 -40.86% 95M
|
Health Technology
|
| O: 2.06%
H: 47.28%
C: 3.11%
results
Acutus Medical Announces CEO Appointment and Preliminary Second Quarter 2022 Revenue Results
Published: 2022-07-21 (Crawled : 12:00) - biospace.com/
AFIB | $0.167 -4.3% -4.49% 400K
|
Health Technology
|
| O: 7.19%
H: 44.3%
C: 10.74%
ceo results
MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results
Published: 2023-04-13 (Crawled : 23:00) - biospace.com/
MDVL 4 | $1.8 -0.56% 250K
|
Health Technology
|
| O: 5.88%
H: 42.96%
C: 22.22%
financial results
ANI Pharmaceuticals Reports Third Quarter 2021 Results
Published: 2021-11-01 (Crawled : 12:00) - biospace.com/
ANIP S | $65.49 1.41% 1.39% 210K
|
Health Technology
|
| O: 9.77%
H: 41.84%
C: 31.63%
results
QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-05-17 (Crawled : 13:20) - biospace.com/
QSAM | $7.78 -31.58% 12K
|
Manufacturing
|
| O: -14.8%
H: 36.38%
C: 36.38%
results
Revance Provides an Update on DAXXIFY® Commercial Launch and Preliminary Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-01-09 (Crawled : 19:00) - biospace.com/
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.17%
H: 0.58%
C: -0.91%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: 15.12%
H: 34.86%
C: 34.07%
daxxify commercial year financial update results
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2020 Results Strengthens Balance Sheet Through Amendment of Loan Agreement with CRG
Published: 2021-01-26 (Crawled : 23:00) - biospace.com/
TTOO A | $2.98 -0.33% -0.34% 34K
|
Health Technology
|
| O: 3.27%
H: 34.01%
C: 28.96%
results
Sharecare announces second quarter 2022 financial results and operational highlights
Published: 2022-08-10 (Crawled : 12:20) - biospace.com/
SHCR | $0.6536 3.11% 3.01% 6.8M
|
|
| O: -7.28%
H: 32.14%
C: 30.71%
results
RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 13:00) - biospace.com/
RDHL | $0.4519 7.39% 6.88% 330K
|
Health Technology
|
| O: 0.0%
H: 30.05%
C: 24.59%
biopharma financial results report results tiona
Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -15.54%
H: 29.6%
C: 27.2%
financial results report results
NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023
Published: 2023-10-10 (Crawled : 11:00) - biospace.com/
NSTG M | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -0.79%
H: 29.6%
C: 17.6%
financial
RAPT Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 17:00) - biospace.com/
RAPT | $7.96 0.38% 0.38% 790K
|
Health Technology
|
| O: 0.11%
H: 29.24%
C: 26.03%
therapeutics financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.